Carl Zeiss Meditec AG has been expanding its ophthalmology business over the last years. Consolidating the product lines into a single Strategic Business Unit led by a proven, experienced leader will facilitate more effective customer service, more aggressive market penetration and global expansion. The company announced that James V. Mazzo will join Carl Zeiss Meditec as Global President of Ophthalmology with responsibility for the new Strategic Business Unit Ophthalmology as well as Carl Zeiss Meditec's U.S. Sales and Service Center.

Jim Mazzo spent over 20 years leading Allergan's North American and European eye care organizations. He led the public spin-off of AMO as Chairman/CEO. In 2009 Abbott Labs purchased AMO and Mazzo was selected as EVP to lead Abbott's global ophthalmology business.

He left Abbott in 2013 to become executive chair and CEO of AcuFocus and Executive Chair of Neurotech.